Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Gains from Investment Securities (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Gains from Investment Securities over the past 16 years, most recently at -$8.9 million for Q2 2025.

  • For Q2 2025, Gains from Investment Securities fell 16860.38% year-over-year to -$8.9 million; the TTM value through May 2025 reached -$6.2 million, down 4204.61%, while the annual FY2025 figure was -$7.8 million, 5215.79% down from the prior year.
  • Gains from Investment Securities for Q2 2025 was -$8.9 million at Lifecore Biomedical, Inc. \De\, down from $133000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $2.4 million in Q4 2024 and troughed at -$8.9 million in Q2 2025.
  • A 5-year average of -$718352.9 and a median of $45000.0 in 2023 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 9500.0% in 2024 and later crashed 16860.38% in 2025.
  • Year by year, Gains from Investment Securities stood at $428000.0 in 2021, then tumbled by 109.35% to -$40000.0 in 2022, then skyrocketed by 162.5% to $25000.0 in 2023, then skyrocketed by 9500.0% to $2.4 million in 2024, then plummeted by 470.12% to -$8.9 million in 2025.
  • Business Quant data shows Gains from Investment Securities for LFCR at -$8.9 million in Q2 2025, $133000.0 in Q1 2025, and $2.4 million in Q4 2024.